The reoxygenation injury: Is it clinically important?  by Allen, Bradley S.
The reoxygenation injury: Is it clinically important?
Bradley S. Allen, MD
See related article on page 105. Repair of cyanotic congenital heart defects necessitating cardiopul-monary bypass (CPB) is becoming more frequent in infants andneonates. Despite apparently successful surgical correction, post-operative myocardial and pulmonary dysfunction continues to be amajor contributor to morbidity and mortality and is more severethan after repair of acquired defects in adults with normoxic con-
ditions.1-3 The neonatal heart also has a reduced response to inotropic agents
compared with the adult heart.1,2 Thus, preservation of myocardial function in
neonates during cardiac operations assumes even greater importance, because a
perioperative insult is less well tolerated and more difficult to treat.
Congenital malformations of the heart frequently lead to physiologic abnormal-
ities (“stress”) that are quite different from those seen in the adult, and so the
concerns during CPB are not necessarily the same. The most common preoperative
stress in adults is ischemia, secondary to coronary artery disease, and the major
concern is avoidance of a “regional” myocardial reperfusion injury with the rein-
troduction of blood.4 In contrast, the most common preoperative stress in pediatric
patients is hypoxia (cyanosis).1,2 The major concern, therefore, is whether a reoxy-
genation injury (similar to a reperfusion injury) occurs with the abrupt reintroduc-
tion of oxygen. The occurrence of such an injury could be even more detrimental,
as it would result in “global ”damage, since hypoxia affects the entire body, not just
the heart.
Acute hypoxia and acidosis may occur as a consequence of many congenital
heart defects and can result in depletion of glycogen, adenosine triphosphate, and
Krebs cycle intermediates, leading to myocardial dysfunction.2,5,6 Significant acute
hypoxia forces the myocardium to rely on anaerobic metabolism, and when acidosis
is present, this further heightens these deleterious effects. Chronic hypoxia leads to
cyanosis, a condition frequently encountered in infants and children undergoing
cardiac operations. Despite compensatory mechanisms, substrate depletion and
metabolic derangements are more common in cyanotic hearts than in normoxic
hearts.1-3,5,6 Moreover, cyanosis depletes the myocardium of endogenous antioxi-
dants, and a growing body of experimental and clinical evidence indicates that this
may make the cyanotic immature heart more susceptible to an oxygen-mediated
injury when molecular oxygen is restored.7-10
The reversal of hypoxemia occurs with initiation of extracorporeal circulation
and precedes the surgical ischemia used for operative repair in children with
cyanotic disease. The conventional method of starting CPB in infants and children
with hypoxemia is to abruptly raise oxygen tension (Po2) to approximately 400 to
500 mm Hg. Does this sudden reintroduction of oxygen causes a significant
“unintended injury” and, if so, can it be prevented? Such an injury might explain
why the cyanotic heart is more vulnerable and less tolerant to subsequent surgical
ischemia than the normoxic heart.1-3,5,6
Corno and colleagues,11 as well as others, have documented experimentally that
a reoxygenation injury does occur after an acute hypoxic insult.7-9 Our studies
support this work.3,10,12 We subjected neonatal piglets to 60 minutes of acute
ventilator hypoxia (fraction of inspired oxygen [FIO2] 8%-10%) and then abruptly
reoxygenated them by increasing the ventilator FIO2 to 100%, or we placed them on
CPB at an FIO2 of 100%, simulating the usual clinical practice. Abrupt reoxygen-
ation by either method caused an oxygen-derived free radical–mediated injury,
resulting in a reduction in cardiac output, depressed myocardial function, elevated
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pulmonary vascular resistance, and a reduction in the
arterial/alveolar ratio. This injury was independent of the
method of reoxygenation; thus, it is related to the sudden
reintroduction of oxygen and not the effects of CPB. Con-
versely, maintaining normoxemia (Po2 80-100 mm Hg)
rather than hyperoxemia during the initiation of CPB and
then gradually increasing oxygen levels substantially re-
duced oxidant damage and decreased the extent of myocar-
dial dysfunction. These benefits coincided with the Po2-
dependent nature of the reoxygenation injury, because free
radical production and myocardial injury after reoxygen-
ation of isolated heart preparations are proportionate to
Po2.13,14 In clinical practice, hyperoxemic CPB is performed
routinely but is likely never needed, because a Po2 of 400 to
500 mm Hg confers only a negligible increase in oxygen
content compared with a Po2 of 100 to 150 mm Hg. In both
instances the oxygen saturation is essentially 100%. More-
over, a CPB Po2 of more than 180 mm Hg has been
associated with impairment of peripheral perfusion.15 The
avoidance of hyperoxemia during reoxygenation in cyanotic
infants to reduce injury may be comparable, in a sense, with
controlling the initial reperfusate after ischemia to avoid a
reperfusion injury.4
Leukocytes may also be active mediators of the reoxy-
genation injury. Activated white cells have been shown to
play a major role in the generation of oxygen-derived free
radicals after ischemia, and it seems logical that they should
contribute to the reoxygenation injury, since both ischemia
and hypoxia subject tissue to low oxygen levels.3,12,16 Leu-
kocyte depletion is a readily available method that allows
the surgeon to safely minimize the harmful effects of neu-
trophils, without risking side effects of pharmacologic in-
terventions aimed at altering leukocyte function or prevent-
ing the free radical injury through the use of exogenous
oxygen radical scavengers. The effect of leukocyte removal
was tested in neonatal piglets after the same acute (60
minutes) hypoxic stress. By use of leukocyte-depleting fil-
ters, the detrimental effects of sudden reoxygenation were
prevented to an even greater extent than with gradual reoxy-
genation (normoxic strategy), with a marked reduction in
oxygen-derived free radical formation, preservation of left
ventricular contractility and diastolic compliance, mainte-
nance of pulmonary alveolar capillary gas exchange
(arterial/alveolar ratio), and only a slight rise in pulmonary
vascular resistance.3,10,12 In fact, the change in pulmonary
vascular resistance was even less than in nonhypoxic ani-
mals subjected to CPB, suggesting that leukocyte filtration
should be used in all pediatric operations where postopera-
tive pulmonary hypertension could be problematic. Several
experimental and clinical studies support this implication
and have documented a reduction in pulmonary injury with
leukocyte filtration even in noncyanotic infants.17,18
Despite these findings, many surgeons still doubt the
existence and the clinical significance of suddenly restoring
oxygen to the hypoxic heart. They point out that the major-
ity of studies that have documented this injury have used an
acute hypoxic injury, which, in contrast to chronic hypoxia
in the infant, may not allow sufficient time for compensa-
tory adaptation to develop. This adaptation, they argue, may
allow the chronically hypoxic patient to avoid an injury with
the reintroduction of oxygen. As such, they believe that this
is an unimportant injury, artificially created in the labora-
tory, and of little clinical significance. The argument of
acute versus chronic is perennial. However, in this case I
believe the argument is tenuous at best, because postreoxy-
genation changes seen after acute experimental hypoxemia
parallel those reported in cyanotic patients who undergo
reoxygenation during CPB.7,8 Moreover, we have now con-
firmed the findings of our acute experimental studies in
cyanotic infants using the same biochemical tests.3,10,12
In this issue of the Journal, Corno and his associates11
attempt to address the major issue in this continuing debate
by comparing the results of reoxygenation after acute and
chronic (2 weeks) hypoxia. To accomplish this goal, they
developed a new chronic hypoxic animal model that closely
mimics the clinical setting. The model is quite ingenious, as
it avoids the problems of previous chronic models that
subjected animals to brief periods of normoxia during feed-
ing and cleaning of their cages. These repeated episodes of
reoxygenation do not usually occur in the clinical setting
and may significantly alter (ie, condition) the response of
the hypoxic heart to reoxygenation; in the same way, re-
peated episodes of ischemia and reperfusion make the isch-
emic heart more tolerant to subsequent ischemic insults.
Although their model is quite innovative and allowed the
animals to undergo chronic hypoxia, the experiment did not
exactly mimic the clinical setting, as rats were 5 weeks old
before hypoxia. In contrast, most hypoxic patients are hy-
poxic either immediately after birth or within the first few
days of life. However, as pointed out by Corno’s group, this
is not always true, because some patients (ie, those with
tetralogy of Fallot) may not become hypoxic for weeks to
months. It is possible that cellular changes (adaptations)
may be different if chronic hypoxia is preceded by a pro-
longed period of normoxia. Nevertheless, this study still
has two important lessons. First, despite any cellular adap-
tations that may develop with chronic hypoxia, an oxygen-
mediated injury (reoxygenation injury) still occurs with the
abrupt reintroduction of oxygen. Second, the injury after
chronic hypoxia is greater than after acute hypoxia. More-
over, despite the 5-week delay in initiating chronic hypoxia,
the results are identical to our findings in hypoxic patients,
where we demonstrated greater oxygen-derived free radical
production in cyanotic (chronic hypoxic) infants compared
with acutely hypoxic animals.3,10,12 The most probable ex-
planation for these results is that chronically hypoxic ani-
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mals (or patients) often become ischemic during periods of
increased stress (tachycardia) or exercise.19,20 This subjects
them to both a hypoxic and an ischemic stress. In contrast,
acute experimental hypoxia usually results in no ischemia.12
It is therefore not surprising that a combination of hypoxia
and ischemia results in a more severe injury with reperfu-
sion.
On the basis of this extensive experimental and clinical
infrastructure, we now routinely use a normoxic CPB strat-
egy combined with leukocyte depletion in all hypoxic (cy-
anotic), hypertrophied, or high-risk normoxic patients. The
CPB circuit is primed and initiated at a Po2 of 80 to 100 mm
Hg (normoxic strategy), and the FIO2 is increased slowly to
30% to 50% as needed over the next 10 to 20 minutes to
maintain a Po2 of 100 to 150 mm Hg. We resort to higher
oxygen levels (FIO2 100%) only if we require a period of
low flow or deep hypothermic circulatory arrest, as Nollert
and associates21 have shown that under these conditions an
increased oxygen content is important for neurologic pro-
tection. A leukocyte-depleting filter is placed in the arterial
line for the entire procedure, and if a blood prime is used, it
is always washed and leukocyte depleted.
To assess the clinical efficacy of this approach, we ret-
rospectively examined all patients undergoing a Norwood
procedure at our institution between July 1, 1996, and
March 31, 2000. There were 72 patients, 41 with a diagnosis
of hypoplastic left heart syndrome (HLHS) and 31 with a
variant (HLHV) of HLHS. The overall survival was 78%
(76% HLHS, 81% HLHV). More important, there was
complete preservation of myocardial function in the patients
with HLHS, both initially, as assessed by echocardiogram
(shortening fraction preoperatively 37%  10% vs postop-
eratively 35%  11%), and several months later, when
evaluated by angiogram (ejection fraction 57%  7%)
before the Glenn procedure. In contrast, the surgical sur-
vival in the 38 patients undergoing a Norwood procedure in
the 2 years before institution of this strategy was only 53%,
and postoperative low output syndrome was a significant
problem. I acknowledge that other changes might have
accounted for these findings, but I believe these results, as
well as the extensive experimental infrastructure, support
the safety and efficacy of this approach.
In summary, although the study by Corno and col-
leagues11 does much to further our knowledge, because of
the age of the animals at the time of hypoxia, some may still
argue that it does not definitively prove that this injury is
clinically important. However, it adds another “piece to the
puzzle” and leaves less room for those who still cling to the
belief that the reoxygenation injury is simply a mirage, and
clinically unimportant. Therefore, perhaps the question
should be why risk any damage, no matter what the severity,
when it is easy to minimize the reoxygenation injury by
using a CPB strategy of normoxia and white blood cell
filtration.
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